Pharmacovigilance and Drug Safety Software Market Size and Forecast (2021–2031)

Pharmacovigilance and Drug Safety Software Market Size and Forecast (2021–2031)

Pharmacovigilance and Drug Safety Software Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Offering (Software and Services), Deployment (Cloud and On-Premises), Enterprise Size (Large Enterprises and SMEs), Form (Standard and Customized), Functionality (Signal and Risk Management, Issue Tracking and Adverse Event Tracking, Case Management, Clinical Safety Management and Clinical Trial Safety, Quality and Compliance, Medical Writing, Audit Support and Training Compliance, Healthcare Analytics, and Others), End User [Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing (BPO) Firms, and Others], and Geography

Send Enquiry
Item ID: TIPHC00002557 Category: Tag:

$3,633 – $6,433

Description

The pharmacovigilance and drug safety software market size was valued at US$ 214.39 million in 2023 and is expected to reach US$ 359.31 million by 2031; it is estimated to record a CAGR of 6.7% from 2023 to 2031.

The pharmacovigilance and drug safety software market is segmented into five major regions—North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. North America dominated the market in 2023, followed by Europe and Asia Pacific, respectively. The pharmacovigilance and drug safety software market in North America is segmented into the US, Canada, and Mexico. North America is witnessing tremendous growth in the pharmacovigilance and drug safety software market, owing to the presence of various market players such as IQVIA Oracle Corporation, who are continuously working on the advancement of pharmacovigilance and drug safety software. In July 2024, Oracle Corporation launched an AI-based Oracle Argus platform as a Safety One Intake solution. This solution helps life science organizations to meet growing regulatory requirements and to mitigate the rising volume of adverse event cases. This new pharmacovigilance platform aimed to increase productivity, improve data privacy, and enhance reporting. Thus, such product innovations by the market players in the region are fueling the growth of the pharmacovigilance and drug safety software market in the area.

Asia Pacific consists of various growing economies such as India, China, Japan, South Korea, Australia, and Rest of Asia Pacific. Asia Pacific is witnessing growing digitization in its healthcare sector. The governments of various countries in the region are taking different initiatives to enhance and digitize the healthcare system. For instance, China’s healthcare expenditure of public financial officials reached US$ 318.5 billion in 2023. According to the India Brand Equity Foundation, the Indian Healthcare industry was valued at US$ 372 billion in 2023, driven by both the public and private sectors. Such rising healthcare expenditure across the Asia Pacific countries has created massive demand for the pharmacovigilance and drug safety software market growth during the forecast period.

Based on enterprise size, the global pharmacovigilance and drug safety software market is bifurcated into SMEs and large enterprises. The large enterprises segment dominated the market for enterprise size in 2023 owing to increasing investment by large companies in pharmacovigilance software. Large organizations with global operations must adhere to the pharmacovigilance guidelines of multiple regions. Pharmacovigilance software helps consolidate and standardize global safety data, ensuring that these organizations can monitor drug safety in real time across multiple geographies. Large organizations receive a high volume of adverse event data, both during clinical trials and post-marketing. Pharmacovigilance software helps these organizations manage and analyze the increasing data volume effectively, reducing the chances of noncompliance or missed safety signals. As pharmacovigilance software processes sensitive patient data, large organizations are adopting software solutions with robust data security and privacy features to ensure compliance with data protection regulations such as the General Data Protection Regulation (GDPR) in Europe.

ArisEurope; ICON plc; Syneos Health; Accenture; IQVIA; Genpact; Cognizant; Paraxel International Corporation; Laboratory Corporation of America Holdings; Max Application; Clinevo Technologies; Qinecsa Solutions; AB Cube; and Veeva Systems are among the key pharmacovigilance and drug safety software market players that are profiled in this market study.

The overall pharmacovigilance and drug safety software market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the pharmacovigilance and drug safety software market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the pharmacovigilance and drug safety software market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmacovigilance and drug safety software market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the pipe relining market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

#CALC!

LIST OF TABLES

Table 1. Pharmacovigilance and Drug Safety Software Market Segmentation
Table 2. List of Vendors
Table 3. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Table 4. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Offering
Table 5. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Deployment
Table 6. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Enterprise Size
Table 7. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Form
Table 8. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by Functionality
Table 9. Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 10. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 11. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 12. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 13. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 14. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 15. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 16. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 17. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 18. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 19. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 20. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 21. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 22. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 23. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 24. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 25. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 26. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 27. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 28. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 29. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 30. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 31. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 32. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 33. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 34. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 35. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 36. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 37. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 38. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 39. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 40. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 41. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 42. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 43. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 44. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 45. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 46. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 47. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 48. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 49. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 50. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 51. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 52. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 53. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 54. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 55. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 56. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 57. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 58. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 59. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 60. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 61. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 62. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 63. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 64. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 65. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 66. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 67. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 68. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 69. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 70. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 71. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 72. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 73. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 74. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 75. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 76. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 77. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 78. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 79. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 80. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 81. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 82. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 83. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 84. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 85. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 86. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 87. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 88. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 89. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 90. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 91. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 92. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 93. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 94. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 95. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 96. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 97. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 98. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 99. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 100. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 101. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 102. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 103. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 104. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 105. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 106. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 107. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 108. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 109. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 110. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 111. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 112. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 113. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 114. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 115. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 116. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 117. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 118. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 119. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 120. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 121. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 122. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 123. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 124. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 125. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 126. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 127. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 128. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 129. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 130. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 131. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 132. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 133. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 134. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 135. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 136. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 137. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 138. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 139. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 140. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 141. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 142. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 143. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 144. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 145. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 146. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 147. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 148. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 149. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 150. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 151. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 152. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 153. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 154. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 155. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 156. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 157. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 158. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 159. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 160. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 161. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 162. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 163. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 164. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 165. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 166. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 167. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 168. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 169. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 170. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 171. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Offering
Table 172. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Deployment
Table 173. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Enterprise Size
Table 174. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Form
Table 175. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by Functionality
Table 176. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 177. Company Positioning & Concentration
Table 178. List of Abbreviation

LIST OF FIGURES

Figure 1. Pharmacovigilance and Drug Safety Software Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Million), 2021–2031
Figure 5. Pharmacovigilance and Drug Safety Software Market Share (%) – by Offering (2023 and 2031)
Figure 6. Software: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Services: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Pharmacovigilance and Drug Safety Software Market Share (%) – by Deployment (2023 and 2031)
Figure 9. Cloud: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. On Premises: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Pharmacovigilance and Drug Safety Software Market Share (%) – by Enterprise Size (2023 and 2031)
Figure 12. Large Enterprises: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. SMEs: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Pharmacovigilance and Drug Safety Software Market Share (%) – by Form (2023 and 2031)
Figure 15. Standard: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Customized: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Pharmacovigilance and Drug Safety Software Market Share (%) – by Functionality (2023 and 2031)
Figure 18. Signal and Risk Management: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Issue Tracking and Adverse Event Tracking: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Case Management: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Clinical Safety Management and Clinical Trial Safety: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Quality and Compliance: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Medical Writing: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Audit Support and Training Compliance: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Healthcare Analytics: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Others: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Pharmacovigilance and Drug Safety Software Market Share (%) – by End User (2023 and 2031)
Figure 28. Pharmaceutical and Biotechnology Companies: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 29. Contract Research Organizations: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. Business Process Outsourcing (BPO) Firms: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Others: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
Figure 32. Pharmacovigilance and Drug Safety Software Market Breakdown by Region, 2023 and 2031 (%)
Figure 33. North America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 35. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 36. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 37. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 38. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 39. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 40. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 41. United States: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Canada: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Mexico: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Europe: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 46. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 47. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 48. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 49. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 50. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 51. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. Germany: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. France: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. United Kingdom: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Italy: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Spain: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. Russia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Asia Pacific: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 60. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 61. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 62. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 63. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 64. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 65. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 66. China: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 67. Japan: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 68. India: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 69. South Korea: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. Australia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. Rest of APAC: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 72. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 73. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 74. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 75. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 76. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 77. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 78. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 79. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 80. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 81. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 82. South Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 83. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 84. South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 85. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
Figure 86. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
Figure 87. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
Figure 88. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
Figure 89. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
Figure 90. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
Figure 91. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 92. Brazil: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 93. Argentina: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 94. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031(US$ Million)
Figure 95. Heat Map Analysis by Key Players

The List of Companies – Pharmacovigilance and Drug Safety Software Market
o ArisGlobal LLC     
o Max Application    
o Oracle Corp         
o Veeva Systems Inc           
o IQVIA Holdings Inc           
o ICON Plc             
o Cognizant Technology Solutions Corp       
o Accenture Plc      
o Syneos Health Inc
o Genpact Ltd.     

Reviews

There are no reviews yet.

Be the first to review “Pharmacovigilance and Drug Safety Software Market Size and Forecast (2021–2031)”